TrialJournal of addiction medicine

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence.

Paul H Earley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.